David Chan
Angel Investor
New York, United States
David Chan is a seed investor in New York focused on Health Care and Medical. Mr. David Chan, CFA is an Advisor at ROBO Global Ventures. He graduated with a B.A. in Biochemistry from Harvard University in 1983 and received an M.B.A. from Columbia University in 1989.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries David Chan invests in
Stages David Chan invests in
Countries David Chan invests in
Round sizes
Round size
- Seed
- $1.3M–$4.6M
Investment Focus
Industry
- Health Care 3 (43%)
- Medical 2 (29%)
- Women's 2 (29%)
- Art 1 (14%)
- Family 1 (14%)
Stage
- Seed 5 (71%)
- Series A 1 (14%)
- Funding Round 1 (14%)
Country
- United States 5 (71%)
- Israel 1 (14%)
- Nigeria 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
StarkWare Industries
|
StarkWare Industries uses Stark technology to develop a full proof stack in generating and verifying proofs of computational integrity. | $30M / Series A / Oct 28, 2018 | |
Wellthy
|
Wellthy is a family care concierge service bringing relief to families managing complex or ongoing care situations. The company's solution brings relief to families managing aging-related concerns, childcare, special needs, health conditions, and other complex or ongoing care situations. Wellthy connects families with a dedicated CareCoordinator to help tackle the logistical and administrative tasks of caring for the ones they love, including themselves.Through Wellthy’s online platform, families can keep track of appointments, save contacts, organize tasks by type, store important documents, and revisit past conversations.The company was founded in 2014 by Lindsay Jurist-Rosner and Kevin Roche and is headquartered in New York, United States. | $4.6M / Seed / Nov 13, 2017 | |
BillionToOne
|
BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to makepre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries.BillionToOne was founded in 2016 and is headquartered in Menlo Park, California. | Seed / Aug 21, 2017 | |
Lidya
|
Lidya is a financial services platform to improve access to credit and finance across frontier and emerging markets starting with Nigeria. We use mobile-first technology with a strong customer experience and proprietary credit scoring algorithms to help small & medium businesses open an account online in 15 minutes, manage funds, and accesscredit needed to grow their businesses and plan their futures. In addition, we have created dashboards and tools to help businesses manage their receivables and cashflow to build credit scores that unlock higher credit limits and affordable rates. Welcome to Lidya. Welcome to the future. | $1.3M / Seed / Mar 29, 2017 | |
The Wing
|
The Wing is a network of work and community spaces designed for women with locations in New York, California, and Washington, D.C. The Wing’s mission is the professional, civic, social, and economic advancement of women through the community. | $2.5M / Seed / Sep 16, 2015 | |
IVY
|
IVY is poised to be the global 21st century version of a top University, with a decentralized lifelong member-base across 50 hub cities. We will disrupt the $4 trillion global education market as the leading platform mobilizing passionate individuals towards entrepreneurship, arts, social impact, policy, and wellness. The average IVY member is aninfluential high income millennial who is 31 years old. Our vision is to establish a lifelong membership spanning from adolescence to late adulthood.IVY has more than 20,000 members across 7 US cities and is hosting 1,000+ gatherings with foremost thought-leaders, cultural institutions, venues, and brands in 2017. It is the number one community that mobilizes the next generation towards entrepreneurship, art, philanthropy, policy and wellness. Founded by Harvard Business School classmates Beri Meric and Philipp Triebel, IVY is currently based across New York, Los Angeles, San Francisco, Washington D.C., Boston, Chicago and Miami, with upcoming international expansions scheduled for London, Hong Kong, and Dubai. | $3.5M / May 01, 2015 | |
Maven Clinic
|
Maven Clinic operates an on-demand digital care clinic that assists mothers and families during conception, throughout pregnancy, and postpartum. It offers video appointments and private messaging with its proprietary women's and family health practitioner network, as well as a family benefits platform. Maven Clinic offers its services forIVF and egg-freezing tracks, pregnancy, postpartum, partner, adoption, surrogacy, and loss tracks, and career coaching and support, and customized manager training for HR. It serves individuals, employers, and healthcare professionals. It was founded in 2014 by Katherine Ryder and is headquartered in New York City. | Seed / Apr 09, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does David Chan invest in?
David Chan invests primarily in Health Care, Medical and Women's startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is David Chan's check size?
David Chan typically joins rounds of $1.3M–$4.6M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds David Chan participates in.
When did David Chan last invest?
The most recent investment recorded for David Chan closed in Oct 2018. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
